Recombinant Bacillus cereus UPF0754 membrane protein BCQ_0944 (BCQ_0944)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Bacillus cereus UPF0754 Membrane Protein BCQ_0944

The Recombinant Bacillus cereus UPF0754 membrane protein BCQ_0944 (BCQ_0944) is a recombinant protein derived from the bacterium Bacillus cereus. This protein is expressed in Escherichia coli and is fused with an N-terminal His tag, facilitating its purification and identification. The protein consists of 378 amino acids and is available in a lyophilized powder form with a purity of greater than 90% as determined by SDS-PAGE .

2.2. Amino Acid Sequence

The amino acid sequence of BCQ_0944 is detailed and provides insights into its structural and functional properties. The sequence is as follows:

MNIWLSMLTTTGLGAIIGGFTNHLAIKMLFRPHRPIYIGKFQVPFTPGLIPKRRDELAVQ LGKMVVEHLLTPEGIGKKLTNEEFQKGLIHWAQVEVDKVITNEQSLRHMLEKWDVAHVEK EATEKIEQVITEKIQSFLEEYYTYTWEQALPHSVHEKIENAIPNVSAFILKRAIHFFESE EGKSRLSKMIDDFFASRGTLLNLVGMFLGNVSVVDRVQPEVIKFLGQDGTKQLLTEVLQK EWEKLKGRDVKEVETFVEKEMIVSSILSAVKVEETVSKFLNQSVQQVCEPVRETIMEKVV PSAVTKGLKWGAENVASILNNLHLAEIVQQEVSTFSTERLEDLVLSITKNELKMITYLGA LLGGMIGIVQGLLLLFLK .

References Frontiers in Microbiology: Bacillus cereus in Ready-to-Eat Foods Creative Biomart: Recombinant Full Length Bacillus Cereus UPF0754 Membrane Protein BCQ_0944 StatPearls: Bacillus cereus PMC: The Bacillus cereus Group: Bacillus Species with Pathogenic Potential

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
BCQ_0944; UPF0754 membrane protein BCQ_0944
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-378
Protein Length
full length protein
Species
Bacillus cereus (strain Q1)
Target Names
BCQ_0944
Target Protein Sequence
MNIWLSMLTTTGLGAIIGGFTNHLAIKMLFRPHRPIYIGKFQVPFTPGLIPKRRDELAVQ LGKMVVEHLLTPEGIGKKLTNEEFQKGLIHWAQVEVDKVITNEQSLRHMLEKWDVAHVEK EATEKIEQVITEKIQSFLEEYYTYTWEQALPHSVHEKIENAIPNVSAFILKRAIHFFESE EGKSRLSKMIDDFFASRGTLLNLVGMFLGNVSVVDRVQPEVIKFLGQDGTKQLLTEVLQK EWEKLKGRDVKEVETFVEKEMIVSSILSAVKVEETVSKFLNQSVQQVCEPVRETIMEKVV PSAVTKGLKWGAENVASILNNLHLAEIVQQEVSTFSTERLEDLVLSITKNELKMITYLGA LLGGMIGIVQGLLLLFLK
Uniprot No.

Target Background

Database Links

KEGG: bcq:BCQ_0944

Protein Families
UPF0754 family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What expression systems are recommended for recombinant BCQ_0944 production?

Escherichia coli remains the predominant expression system for BCQ_0944 protein production, with documented success in achieving protein purity greater than 90% as determined by SDS-PAGE analysis . The standard methodology involves:

  • Cloning the BCQ_0944 gene into an expression vector with an N-terminal His-tag

  • Transforming the construct into an E. coli expression strain

  • Inducing protein expression under optimized conditions

  • Cell lysis and protein purification using affinity chromatography

  • Using specialized E. coli strains designed for membrane protein expression (C41, C43)

  • Optimizing induction temperature (typically lower temperatures of 16-25°C)

  • Employing milder detergents during purification to maintain protein structure

  • Testing multiple fusion tags beyond His-tag (MBP, GST) to improve solubility

What are the recommended storage and handling protocols for recombinant BCQ_0944?

For optimal stability and activity of recombinant BCQ_0944 protein, follow these evidence-based protocols:

  • Storage form: The protein is typically supplied as a lyophilized powder .

  • Reconstitution: Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL .

  • Storage buffer: Tris/PBS-based buffer with 6% trehalose, pH 8.0 is recommended .

  • Long-term storage: Store at -20°C/-80°C upon receipt, with aliquoting necessary for multiple use scenarios .

  • Glycerol addition: Add 5-50% glycerol (final concentration) to aliquots for long-term storage at -20°C/-80°C .

  • Handling caution: Avoid repeated freeze-thaw cycles as they significantly reduce protein stability .

  • Working storage: Store working aliquots at 4°C for up to one week .

  • Preparation before use: Briefly centrifuge vials prior to opening to bring contents to the bottom .

What strategies can improve expression yields of BCQ_0944 membrane protein?

Optimizing expression of membrane proteins like BCQ_0944 requires addressing several technical challenges:

Codon Optimization Strategies

Recent research demonstrates that the accessibility of translation initiation sites (modeled using mRNA base-unpairing across the Boltzmann's ensemble) significantly outperforms alternative features for predicting expression success . Implementation strategies include:

  • Using tools like TIsigner that employ simulated annealing to modify the first nine codons of mRNAs with synonymous substitutions

  • Focusing on accessibility of the target region rather than just codon adaptation index

  • Making modest synonymous changes that are sufficient to tune recombinant protein expression levels

Expression Conditions Optimization

ParameterStandard ConditionOptimized Condition for Membrane ProteinsRationale
Temperature37°C16-25°CSlower expression allows proper membrane insertion
Inducer concentration1 mM IPTG0.1-0.5 mM IPTGGentler induction prevents inclusion body formation
MediaLBTerrific Broth or Auto-induction mediaProvides more nutrients and gradual induction
Growth phaseMid-log phaseLate-log phaseCells have developed robust translation machinery
AdditivesNoneGlycerol, sorbitol, or specific lipidsStabilizes membrane and promotes proper folding

Fusion Partners Selection

Evidence suggests that specific fusion partners can significantly enhance membrane protein expression and solubility:

  • MBP (Maltose Binding Protein) - Enhances solubility while maintaining membrane targeting

  • SUMO (Small Ubiquitin-like Modifier) - Improves folding and can be precisely removed

  • Thioredoxin - Promotes disulfide bond formation when needed

How can structural and functional characterization of BCQ_0944 be approached?

Comprehensive characterization requires integrating multiple complementary techniques:

Structural Analysis Workflow

  • Initial screening: Circular dichroism (CD) spectroscopy to confirm secondary structure elements

  • Detergent screening: Systematic testing of detergents (DDM, LMNG, etc.) for protein stability

  • Advanced structural methods:

    • X-ray crystallography (challenging for membrane proteins)

    • Cryo-electron microscopy (increasingly popular for membrane proteins)

    • NMR for dynamic regions (especially extramembrane domains)

Functional Analysis Approaches

Given the uncharacterized nature of UPF0754 family proteins, multiple parallel approaches are recommended:

  • Genetic approaches:

    • Gene knockout studies in Bacillus cereus

    • Complementation assays to verify function

    • Transcriptional analysis under various conditions

  • Biochemical approaches:

    • ATPase/GTPase activity assays if relevant

    • Binding partner identification using pull-down assays

    • Reconstitution in proteoliposomes for transport studies

  • Split-Ubiquitin technique for mapping protein-protein interactions:
    This technique is particularly valuable for membrane proteins as it:

    • Allows detection of protein interactions in their native membrane environment

    • Provides direct readout of proximity between proteins

    • Can identify both stable and transient interactions

How can the split-Ubiquitin technique be optimized for studying BCQ_0944 interactions?

The split-Ubiquitin (split-Ub) technique is particularly valuable for studying membrane protein interactions in vivo. For BCQ_0944, the methodology can be implemented as follows:

Basic Principle Implementation

The technique involves splitting ubiquitin into N-terminal (Nub) and C-terminal (Cub) fragments. When brought into proximity, they reassemble into quasi-native Ub that is recognized by ubiquitin-specific proteases (UBPs), which cleave any C-terminally attached reporter protein .

For BCQ_0944 studies:

  • Fuse BCQ_0944 to the Cub domain and a reporter protein (such as RUra3p)

  • Fuse potential interaction partners to the Nub domain

  • When interaction occurs, the reporter protein is cleaved, providing a readout

Optimization Strategies

  • Utilize modified Nub variants: Use Nua (alanine) or Nug (glycine) at position 13 of Nub instead of wild-type isoleucine to reduce background interaction

  • Reporter selection: RUra3p reporter provides a growth selection readout on appropriate media

  • Control design: Include both positive controls (known interactors) and negative controls (proven non-interactors)

  • Quantitative measurement: Implement quantitative assays to measure the strength of interactions

What bioinformatic approaches are most effective for predicting BCQ_0944 function?

Functional prediction for uncharacterized membrane proteins like BCQ_0944 requires integrated computational approaches:

Comprehensive Annotation Pipeline

Analysis StageTools/MethodsExpected Output
Sequence AnalysisBLAST, HMMER, PfamIdentification of conserved domains and homologs
Structural PredictionTMHMM, PSIPRED, AlphaFold2Prediction of transmembrane regions and 3D structure
Evolutionary AnalysisConSurf, EvolutionaryTraceIdentification of functionally important residues
Genomic ContextSTRING, GeConTIdentification of functionally related genes
Protein-Protein InteractionInterProScan, STITCHPrediction of potential interaction partners

Machine Learning Approaches

Recent advances in deep learning have improved prediction accuracy for membrane protein function:

  • Graph neural networks that incorporate protein structure information

  • Transfer learning models trained on characterized membrane proteins

  • Ensemble methods that integrate multiple predictors for consensus predictions

What experimental designs are most appropriate for studying BCQ_0944 in pathogenic contexts?

Given that Bacillus cereus is a pathogen associated with food poisoning, research on BCQ_0944 may have implications for pathogenicity and host interactions.

Quasi-experimental Design Options

Using the hierarchy of quasi-experimental designs , the following approaches are recommended:

  • Pre-post intervention studies with control groups:

    • Intervention group: Wild-type B. cereus strain

    • Control group: BCQ_0944 knockout strain

    • Measurements before and after exposure to host cells or stress conditions

  • Interrupted time-series design:

    • Multiple observations before and after genetic modification

    • Allows for tracking temporal changes in phenotype

Pathogenicity Assessment Framework

Experimental ApproachMethodologyOutcome Measures
Virulence gene expressionRT-qPCR, RNA-SeqDifferential expression of virulence genes in WT vs. knockout
Biofilm formationCrystal violet assay, Confocal microscopyQuantification of biofilm formation capacity
Antibiotic resistanceMIC determinationChanges in susceptibility to antibiotics
Host cell interactionCell culture infection modelsAdhesion, invasion, cytotoxicity
In vivo modelsAppropriate animal modelsColonization, disease progression

Consider that B. cereus strains often exhibit resistance to β-lactam antibiotics and rifamycin , which should be accounted for in experimental designs.

What are the most effective purification protocols for BCQ_0944?

For membrane proteins like BCQ_0944, standard purification protocols require modification:

Detailed Purification Protocol

  • Cell lysis:

    • Mechanical disruption (French press or sonication) in buffer containing protease inhibitors

    • Addition of appropriate detergents (starting with milder ones like DDM or LMNG)

  • Initial purification:

    • Immobilized metal affinity chromatography (IMAC) using the N-terminal His-tag

    • Washing with increasing imidazole concentrations to remove non-specific binding

  • Secondary purification:

    • Size exclusion chromatography to separate monomeric from oligomeric forms

    • Ion exchange chromatography if additional purity is required

  • Quality assessment:

    • SDS-PAGE with Coomassie staining (expect >90% purity)

    • Western blot using anti-His antibodies

    • Circular dichroism to confirm proper folding

How can expression issues with BCQ_0944 be systematically troubleshooted?

When facing expression challenges with BCQ_0944, implement this systematic troubleshooting approach:

Diagnostic Framework for Expression Problems

IssueDiagnostic TestPotential Solutions
No expression detectedWestern blot with anti-His tagTry different E. coli strains (BL21, C41/C43, Rosetta)
Protein in inclusion bodiesSolubility analysis of cell fractionsLower induction temperature; reduce IPTG concentration
Poor membrane insertionMembrane fraction analysisCo-express with chaperones; use specialized strains
Protein degradationTime-course analysis post-inductionAdd protease inhibitors; reduce induction time
Low yieldQuantification of purified proteinOptimize codon usage; use TIsigner to improve translation initiation

Translation Initiation Optimization

Research indicates that accessibility of translation initiation sites is a critical factor in successful recombinant protein expression . For BCQ_0944:

  • Analyze the mRNA structure around the start codon

  • Use TIsigner to design synonymous substitutions in the first nine codons

  • Test multiple constructs with varying 5' UTR sequences

  • Monitor expression levels using reporter systems before scaling up

How does BCQ_0944 compare to other bacterial membrane proteins in the UPF0754 family?

Comparative analysis provides insights into conservation and specialization of BCQ_0944:

Evolutionary Conservation Analysis

While specific functional data on the UPF0754 protein family is limited, comparative genomics approaches can reveal:

  • Highly conserved residues across species (likely functional importance)

  • Bacillus-specific regions (potential specialization)

  • Predicted structural similarities to characterized membrane proteins

Genomic Context Comparison

Examining the genomic neighborhood of BCQ_0944 in different Bacillus species can provide functional hints:

  • Co-transcribed genes suggest related functions

  • Conservation of gene order across species indicates functional relationships

  • Presence in specific operons may reveal involvement in particular cellular processes

What are the implications of BCQ_0944 research for understanding B. cereus pathogenicity?

Bacillus cereus is known for causing food poisoning through the production of various toxins . Research on BCQ_0944 may contribute to understanding pathogenicity mechanisms:

Potential Roles in Virulence

  • Membrane integrity: As a membrane protein, BCQ_0944 may contribute to survival under host conditions

  • Toxin secretion: Potential involvement in secretion systems for toxin export

  • Environmental sensing: Possible role in detecting host environments

  • Antimicrobial resistance: Contribution to intrinsic resistance mechanisms

Research Integration with B. cereus Pathogenicity Studies

B. cereus strains commonly harbor various enterotoxin genes (hblACD, nheABC) and exhibit antimicrobial resistance . Studies on BCQ_0944 should consider:

  • Differential expression under conditions that induce virulence gene expression

  • Potential interactions with known virulence factors

  • Impact on antimicrobial susceptibility profiles

  • Role in biofilm formation and persistence

What emerging technologies hold promise for advancing BCQ_0944 research?

Several cutting-edge approaches are particularly relevant for future BCQ_0944 studies:

Structural Biology Advancements

  • Cryo-EM for membrane proteins: Recent advances in cryo-EM make it increasingly feasible to resolve membrane protein structures without crystallization

  • Integrative structural biology: Combining multiple techniques (X-ray, NMR, cryo-EM, molecular dynamics) for comprehensive structural characterization

  • In-cell structural studies: Emerging methods to study protein structure in native cellular environments

Functional Genomics Approaches

  • CRISPRi for conditional knockdowns: When complete knockouts are lethal or severely affect growth

  • Ribosome profiling: To understand translation dynamics of BCQ_0944

  • Proximity labeling: To identify interaction partners in native membrane environments

How might BCQ_0944 research contribute to antimicrobial development strategies?

Given the increasing concern about antimicrobial resistance in pathogenic bacteria, membrane proteins represent potential novel targets:

Target Validation Framework

  • Essentiality assessment: Determine if BCQ_0944 is essential for B. cereus survival or virulence

  • Structural uniqueness: Evaluate structural differences from host proteins to enable selective targeting

  • Druggability analysis: Identify potential binding pockets using computational approaches

  • Proof-of-concept studies: Develop tool compounds to validate BCQ_0944 as a therapeutic target

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.